Menu
GeneBe

6-131808037-T-C

Variant summary

Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PVS1PM2

The NM_006208.3(ENPP1):c.2T>C(p.Met1?) variant causes a start lost change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000404 in 766,792 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000055 ( 0 hom., cov: 16)
Exomes 𝑓: 0.000039 ( 0 hom. )

Consequence

ENPP1
NM_006208.3 start_lost

Scores

5
3
7

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.458
Variant links:
Genes affected
ENPP1 (HGNC:3356): (ectonucleotide pyrophosphatase/phosphodiesterase 1) This gene is a member of the ecto-nucleotide pyrophosphatase/phosphodiesterase (ENPP) family. The encoded protein is a type II transmembrane glycoprotein comprising two identical disulfide-bonded subunits. This protein has broad specificity and cleaves a variety of substrates, including phosphodiester bonds of nucleotides and nucleotide sugars and pyrophosphate bonds of nucleotides and nucleotide sugars. This protein may function to hydrolyze nucleoside 5' triphosphates to their corresponding monophosphates and may also hydrolyze diadenosine polyphosphates. Mutations in this gene have been associated with 'idiopathic' infantile arterial calcification, ossification of the posterior longitudinal ligament of the spine (OPLL), and insulin resistance. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 10 ACMG points.

PVS1
Start lost variant, no new inframe start found.
PM2
Very rare variant in population databases, with high coverage;

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
ENPP1NM_006208.3 linkuse as main transcriptc.2T>C p.Met1? start_lost 1/25 ENST00000647893.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
ENPP1ENST00000647893.1 linkuse as main transcriptc.2T>C p.Met1? start_lost 1/25 NM_006208.3 P1
ENPP1ENST00000486853.1 linkuse as main transcriptn.22T>C non_coding_transcript_exon_variant 1/42
ENPP1ENST00000513998.5 linkuse as main transcriptc.2T>C p.Met1? start_lost, NMD_transcript_variant 1/255

Frequencies

GnomAD3 genomes
AF:
0.0000687
AC:
5
AN:
72740
Hom.:
0
Cov.:
16
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00249
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.0000389
AC:
27
AN:
694028
Hom.:
0
Cov.:
21
AF XY:
0.0000435
AC XY:
14
AN XY:
322080
show subpopulations
Gnomad4 AFR exome
AF:
0.0000748
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00173
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000158
Gnomad4 OTH exome
AF:
0.0000441
GnomAD4 genome
AF:
0.0000550
AC:
4
AN:
72764
Hom.:
0
Cov.:
16
AF XY:
0.0000896
AC XY:
3
AN XY:
33480
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00200
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000843
Hom.:
0

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingInvitaeSep 27, 2023The frequency data for this variant in the population databases is considered unreliable, as metrics indicate insufficient coverage at this position in the gnomAD database. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. This variant has not been reported in the literature in individuals affected with ENPP1-related conditions. This sequence change affects the initiator methionine of the ENPP1 mRNA. The next in-frame methionine is located at codon 53. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.63
D
BayesDel_noAF
Uncertain
0.080
Cadd
Benign
22
Dann
Benign
0.85
DEOGEN2
Benign
0.27
T;T
Eigen
Uncertain
0.20
Eigen_PC
Benign
0.13
FATHMM_MKL
Benign
0.54
D
M_CAP
Pathogenic
0.95
D
MetaRNN
Pathogenic
0.98
D;D
MetaSVM
Benign
-0.29
T
MutationTaster
Benign
1.0
D
PROVEAN
Benign
-0.36
N;.
REVEL
Uncertain
0.47
Sift
Pathogenic
0.0
D;.
Sift4G
Pathogenic
0.0
D;.
Polyphen
0.93
P;P
Vest4
0.51
MutPred
0.98
Gain of phosphorylation at M1 (P = 0.005);Gain of phosphorylation at M1 (P = 0.005);
MVP
0.86
ClinPred
0.41
T
GERP RS
4.5
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.8
Varity_R
0.79
gMVP
0.18

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1781299830; hg19: chr6-132129177; API